LakeShore Biopharma Co (FRA:H6Z0) Float Percentage Of Total Shares Outstanding: 62.34% (As of Jul. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:H6Z0 LakeShore Biopharma Co Ltd FRA:H6Z0
17 GF Score
Price €0.67
View Full Analysis

What is LakeShore Biopharma Co Float Percentage Of Total Shares Outstanding?

LakeShore Biopharma Co FRA:H6Z0 17 Float Percentage Of Total Shares Outstanding is 62.34% as of Jul. 31, 2026. GuruFocus rates FRA:H6Z0 with a GF Score™ of 17/100.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, LakeShore Biopharma Co's float shares is 25.69 Mil. LakeShore Biopharma Co's total shares outstanding is 41.21 Mil. LakeShore Biopharma Co's float percentage of total shares outstanding is 62.34%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, LakeShore Biopharma Co's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, LakeShore Biopharma Co's Institutional Ownership is 0.01%.

FRA:H6Z0
17GF Score
LakeShore Biopharma Co Ltd FRA:H6Z0
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LakeShore Biopharma Co Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

LakeShore Biopharma Co's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=25.69/41.21
=62.34%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 62.34% mean?
LakeShore Biopharma Co (FRA:H6Z0) has a Float Percentage Of Total Shares Outstanding of 62.34% as of Jul. 31, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Float Percentage Of Total Shares Outstanding too high?
LakeShore Biopharma Co's current Float Percentage Of Total Shares Outstanding is 62.34%. Overall, LakeShore Biopharma Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does LakeShore Biopharma Co's Float Percentage Of Total Shares Outstanding compare to ACUT and PPCB?
LakeShore Biopharma Co's Float Percentage Of Total Shares Outstanding of 62.34% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Float Percentage Of Total Shares Outstanding is 62.34%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (FRA:H6Z0) has a current Float Percentage Of Total Shares Outstanding of 62.34%. The current Float Percentage Of Total Shares Outstanding is 62.34%. LakeShore Biopharma Co's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For LakeShore Biopharma Co (FRA:H6Z0), the current Float Percentage Of Total Shares Outstanding is 62.34% as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Other Exchanges LSBCF:USA
Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
17GF Score

Get the complete analysis for FRA:H6Z0

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.67
Price